EMA Calls for Transparency, Collaboration in COVID-19 Studies
The European Medicines Agency (EMA) is urging transparency and collaboration on COVID-19 studies to facilitate more robust results. "High-quality observational [...]
EMA Reportedly Preparing Q&A Guidance on Big Data
The European Medicines Agency (EMA) is reportedly preparing new guidance on the application of EU data rules for secondary use [...]
Advertisement
